| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $23.2M | +308.0% |
| R&D Expense | $4.4M | -4.2% |
| SG&A Expense | $43.3M | +184.6% |
| Operating Income | -$55.7M | -41.6% |
| Pre-tax Income | -$57.7M | -8.2% |
| Income Tax | $1K | -39.3% |
| Net Income | -$57.7M | -8.2% |
| EPS (Basic) | -$1.80 | +25.9% |
| EPS (Diluted) | -$1.80 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.3M | +120.9% |
| Accounts Receivable | $448K | +118.6% |
| Inventory | $2.7M | +85.1% |
| Current Assets | $46.8M | +121.2% |
| Total Assets | $74.9M | +196.6% |
| Current Liabilities | $8.6M | +115.3% |
| Total Liabilities | $48.0M | +224.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.1M | -32.5% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$3.0M | +9.2% |
| Financing Cash Flow | $57.3M | +32.6% |
| Free Cash Flow | -$34.1M | -31.9% |
| +25.9% |
| Stockholders' Equity |
| $26.9M |
| +157.3% |